Abbvie Announces Venetoclax Receives 3rd Breakthrough Therapy Designation from the FDA
January 28, 2016 at 04:29 AM EST
AbbVie (NYSE: ABBV) announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for the ...